July 1, 2023 Comments Off on New tentative approval for Mylan Labs drug posaconazole Posted in: Tentative Approval [![posaconazole structure](https://www.DrugPatentWatch.com/img/drug-structure/posaconazole.png)](//www.DrugPatentWatch.com/p/preview/generic-api/posaconazole?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Posaconazole is the ge…
July 1, 2023 Comments Off on New patent for Pharmacyclics Inc drug IMBRUVICA Posted in: Patent Added Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in three NDAs. It is available from one supplier. There are fifty-five patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appe…